AQUESTIVE THERAPEUTICS INC (AQST) — institutional ownership
190 funds reported holding AQUESTIVE THERAPEUTICS INC in their latest 13F filings, worth $344M in total (CUSIP 03843E104).
Largest holders
- Bratton Capital Management, L.P. — $40.8M
- VANGUARD GROUP INC — $38.1M
- BlackRock, Inc. (BLK) — $33.6M
- RTW INVESTMENTS, LP — $30.9M
- VANGUARD CAPITAL MANAGEMENT LLC — $19.1M
- FEDERATED HERMES, INC. (FHI) — $12.9M
- STATE STREET CORP (STT, STT-PG) — $12.2M
- GEODE CAPITAL MANAGEMENT, LLC — $10.9M
- Samsara BioCapital, LLC — $10.4M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $6.94M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
Insider buying and selling at AQUESTIVE THERAPEUTICS INC
Who owns the most AQST stock?
The largest institutional holders in the latest 13F filings are Bratton Capital Management, L.P. ($40.8M), VANGUARD GROUP INC ($38.1M), BlackRock, Inc. (BLK) ($33.6M).
How many funds own AQST?
190 funds reported holding it, worth $344M in total.